Shanghai, China, 23 April, 2021 – The Orkid® intrauterine insemination catheter (“Orkid®”), a product by Shanghai Horizon Medical Technology Co., Ltd. (“Horizon Medical®”), a subsidiary of MicroPort Scientific Corporation (00853.HK), has recently received the registration certificate from the Shanghai Municipal Drug Administration.
The Orkid® intrauterine insemination catheter is suitable for intrauterine insemination (IUI) in assisted reproductive technologies. With a soft, smooth tip, the catheter minimizes discomfort effectively and transports the sperm gently when entering the uterus cavity. The product has undergone rigorous positive and negative pressure tests to ensure no intraoperative fluid or air leak. The product is available in straight and curved versions to meet the different clinical needs.
Dr. Guo Zong, General Manager of Horizon Medical®, said, “The approval of Orkid®️ marks further diversification of the Horizon Medical® product portfolio in the field of assisted reproduction. In the future, Horizon Medical® will continue to pursue innovative research and development in conjunction with the clinical needs of patients and doctors, providing doctors with safer and more reliable solutions and to bring patients with the hope of conceiving new lives.”
Artificial insemination is an assisted reproductive technology that artificially introduces semen or sperm into the vagina or uterine cavity to facilitate fertilization. It can be categorized into intravaginal insemination (IVI), intracervical insemination (ICI), intrauterine insemination (IUI) and Intratubal Insemination (ITI), depending on the location of insemination. The IUI technique involves the injection of a certain amount of high-motility sperm gathered through an in vitro process into the uterine cavity. This technique has become increasingly accepted by patients and more widely used in clinical treatment of infertility that is caused either by semen abnormalities in male patients or by cervical problems, endometriosis and ovulation disorders in female patients.
Previously, the Lotus™ single-use sterile ovum aspiration needle and Daylily® embryo transfer catheter, two proprietary products developed by Horizon Medical®, have been approved for marketing and launched in China. Both products have been highly recognized by experts in clinical practice.